Dr. Pamer’s research focuses on the impact of the intestinal microbiota on resistance to Vancomycin-resistant Enterococcus faecium, Clostridium difficile and Klebsiella pneumoniae infections in patients receiving cancer treatment, with a specific focus on highly immunocompromised patients undergoing allogeneic hematopoietic stem cell transplantation. The Pamer laboratory also investigates the role of inflammatory monocytes in defense against infection and the interaction between intestinal microbes and the mammalian immune system.
Training
- MD, 1982, Case Western Reserve, Medicine
- Residency, 1985, University of California, San Diego, Internal Medicine
- Chief Resident, 1986, University of California, San Diego, Internal Medicine
- Fellowship, 1989, University of California, San Diego, Infectious Diseases
- Research Fellowship, 1990, Scripps Clinic and Research Foundation, Research